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We tested the hypothesis that airway wall dimensions are important determinants for the mechani-
cal properties of airways. Lung tissue was obtained from 31 smokers with different degrees of
chronic obstructive pulmonary disease (COPD) who were operated on for a solitary lung lesion. Seg-
ments of small airways (n 
 
5
 
 35) were mounted on cannulas in an organ bath and inflated and de-
flated cyclically between 
 
1
 
15 and 
 
2
 
15 cm H
 
2
 
O. For each airway this was done at baseline, after
methacholine, and after isoprenaline. Specific compliance (sCdyn), specific hysteresis (s
 
h
 
), and pres-
sure at which the airways collapsed (Pcol) were calculated from each recording. Airway wall dimen-
sions were measured morphometrically. Lung function parameters of airflow obstruction were corre-
lated to sCdyn, s
 
h
 
, and Pcol. At baseline, after methacholine, and after isoprenaline sCdyn was 0.059,
 
0.052, and 0.085 cm H
 
2
 
O
 
2
 
1
 
, s
 
h
 
 was 13.5, 12.9, and 7.1%, and Pcol was 
 
2
 
3.4, 
 
2
 
3.5, and 
 
2
 
1.9 cm H
 
2
 
O,
respectively. Differences between sCdyn, s
 
h
 
, and Pcol after methacholine and after isoprenaline
were highly significant (p 
 
,
 
 0.001). Of all dimensions studied, smooth muscle area, but not total wall
area, was the most important determinant for sCdyn and for s
 
h
 
 after methacholine. Specific hystere-
sis at baseline correlated to residual volume as a fraction of total lung capacity (RV/TLC) (r 
 
5
 
 0.5, p 
 
5
 
0.05) and, in the presence of methacholine, to FEV
 
1
 
/FVC (r = 
 
2
 
0.68, p 
 
5
 
 0.02) and RV/TLC (r 
 
5
 
 0.5,
p 
 
5
 
 0.05). We conclude that, in this study, smooth muscle area and smooth muscle tone, but not to-
tal wall area, are determinants for compliance, hysteresis, and collapsibility of isolated airways ob-
tained from smokers. 
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In chronic obstructive pulmonary disease (COPD) airway in-
flammation is associated with increased airway wall thickness
(1). This thickness is relatively more severe in peripheral air-
ways than in central airways, and is more pronounced in pa-
tients with more severe airflow obstruction (1). Similar find-
ings were obtained in patients who died with or from asthma
(2, 3). Thickening of the airway wall as such has little effect on
airway resistance (1). However, in combination with smooth
muscle shortening it causes an important increase of airway
resistance (4, 5). The extent to which the smooth muscle in air-
ways of patients with COPD shortens will depend on the force
it develops and on the load against which the smooth muscle
has to contract. Increased smooth muscle force in COPD has
been described by some investigators (6) but not by others (7).
Isotonic shortening was decreased in airway muscle from pa-
tients with COPD compared with smokers without airflow ob-
struction (8). These findings suggest that in COPD the load on
the bronchial smooth muscle might be increased. In fact,
chronic airway inflammation is associated with deposition of
fibrous tissue such as collagen and elastin within different
compartments of the airway wall (9–13). This probably makes
airways stiffer (i.e., less compliant) and increases the load
against which the smooth muscle contracts. We hypothesize
that airway wall thickness is an important determinant of the
mechanical properties of airways and that reduced compliance
makes the airways less collapsible and decreases their distensi-
bility and hysteresis.
This study was undertaken to evaluate the relation be-
tween compliance, collapsibility, and hysteresis, on the one
hand, and wall dimensions of human peripheral airway seg-
ments on the other hand. Therefore, we have developed an ex-
perimental model to study compliance, hysteresis, and collaps-
ibility of isolated human small airway segments at baseline
tone and after maximal contraction and relaxation of the air-
way smooth muscle.
 
METHODS
 
Study Population
 
Lung tissue was obtained from 31 patients who had a lobar resection
or pneumonectomy for a peripheral lung lesion. These patients were
 
(
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mostly smokers and were classified as “COPD” although one-third
had a lung function within the normal range and, therefore, did not
strictly fulfil the American Thoracic Society criteria (14). Preopera-
tive routine lung function was obtained from 27 of 31 patients. Forced
expiratory volume in one second (FEV
 
1
 
), forced vital capacity (FVC),
maximal flows at 50% ( max
 
50
 
) and 25% ( max
 
25
 
) of FVC, func-
tional residual capacity (FRC), total lung capacity (TLC), residual
volume (RV), and RV as a fraction of TLC (RV/TLC% pred) are all
expressed as percentage of predicted (15). We used FEV
 
1
 
, expressed
as a percentage of FVC (FEV
 
1
 
/FVC), as an indicator of the severity of
airflow obstruction. Reversibility of bronchial obstruction was ex-
pressed as the absolute change in FEV
 
1
 
 as a percentage of the pre-
dicted FEV
 
1
 
 (
 
D
 
FEV
 
1
 
% pred) and as a percentage of the actual pre-
bronchodilator FEV
 
1
 
 (
 
D
 
FEV
 
1
 
% ini). This protocol was approved by
the institutional review board for human studies.
 
Airway Segments
 
Lung tissue was collected and transported on ice in carbogenated
(5%CO
 
2
 
, 95% O
 
2
 
) Krebs-Henseleit buffer (composition in mM: NaCl
118, KCl 4.7, CaCl
 
2
 
 2.5, MgSO
 
4
 
 1.2, KH
 
2
 
PO
 
4
 
 1.2, NaHCO
 
3
 
 25, glucose
5.55). Peripheral airways were identified, cannulated with a thin plas-
tic cannula, and dissected out with surrounding parenchyma. The air-
ways were stored overnight in carbogenated Krebs-Henseleit buffer at
4
 
8
 
 C. Next morning, parenchyma and blood vessels were removed
with the help of a dissection microscope (Stemi 2000; Carl Zeiss,
Oberkochen, Germany) and all side branches identified and ligated in
a watertight fashion. Airway segments at least 5 mm in length were se-
lected for 
 
in vitro
 
 measurements. The internal diameters of the end-
ings of the airways were estimated using the microscope by selecting
stainless steel cannulas (1, 1.5, 2, 3, or 4 mm) that most closely fitted
the diameter of the airway. Next, the airways were mounted in the or-
gan bath on the cannulas in a watertight fashion. The airways were
perfused to test for patency and possible leaks. The length of the un-
stretched airway within the inner borders of the cannula sutures was
measured by a digital calipers (precision 0.1 mm). Next, we stretched
V
·
V
·
 
the airway to 140% of this length, that being the estimated length of
an airway close to TLC (16). At this length the airway remained
patent at low transmural pressures and after contraction by metha-
choline. The volume (
 
m
 
l) of the airway was estimated by the formula
 
p
 
 r
 
2
 
 l, where r is the average of the radius (mm) of the two cannulas
and l is the length (mm) of the stretched airway.
 
Description of Experimental Setup
 
Figure 1 shows the experimental setup we used to measure the dy-
namic properties of the airway segments. It consists of a double-jack-
eted organ bath in which the cannulated airway segment was
mounted. The organ bath is filled with Krebs-Henseleit buffer at a
temperature of 37
 
8
 
 C and continuously gassed with carbogen. Airway
segment and tubing are filled with buffer. All connecting tubing has a
low compliance. Pressure was measured at both ends of the airway
segment (P
 
prox
 
 and P
 
dist
 
) using pressure transducers with a low compli-
ance (143 PC 
 
6
 
 1 psi; Micro Switch, Freeport, IL). The compliance of
the whole system was 0.03 
 
m
 
l cm H
 
2
 
O
 
2
 
1
 
. By means of a 3-way valve,
the airway segment can be connected to a gas-tight syringe mounted
on a computer-controlled, high-precision syringe pump (Harvard 22;
Harvard Apparatus Inc., South Natick, MA) for cyclic inflation and
deflation. Furthermore, the segment can be connected to a microple-
thysmograph that was designed to measure small volume displace-
ments from or to the airway under isobaric conditions. Finally, the
segment can be connected to a reservoir filled with buffer for perfu-
sion. The transmural pressure signals (P
 
prox
 
 and P
 
dist
 
), the volume sig-
nal of the syringe pump, and the volume signal of the microplethys-
mograph (P
 
diff
 
) are all displayed on the computer monitor. The system
is servo-controlled, with the pressure signal from P
 
prox
 
 being used to
control the syringe pump.
 
Measurement Protocol
 
The Krebs buffer in the organ bath was replaced every 15 min
throughout the experiments. Between tests the airway was perfused
for 10 min. The speed of the pump for inflation and deflation was set
Figure 1. Diagram of the experimental setup to measure dynamic properties of isolated airway segments.
A 5 cannulated airway; Vprox and Vdist 5 valves located at the proximal or distal end of the airway; Vpump 5
valve to connect pump to airway; Pprox and Pdist 5 pressure transducers to measure the transmural pres-
sure at the proximal and distal ends of the airway; microplethysmograph 5 device to measure small vol-
ume displacements under isobaric conditions; multichannel registration 5 system for processing of pres-
sure and volume signals; high-precision pump 5 pump for cyclic inflation and deflation of airway. The
system is servo-controlled, with the pressure signal from Pprox controlling the syringe pump.
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at 8 times the estimated volume of the airway segment per minute.
From a pilot study, we estimated that this would give a cycling rate be-
tween 1 and 4 cycles per minute.
 
Leak test.
 
 To test for a leak, the airway was inflated by the pump
until a transmural pressure of 15 cm H
 
2
 
O was obtained. Next, the
spontaneous rate of pressure drop of the segment within the first
minute of inflation was recorded. In case of leakage it was either im-
possible to inflate the airway to 15 cm H
 
2
 
O, or its transmural pressure
dropped rapidly to 0 cm H
 
2
 
O after inflation stopped.
 
Pressure–volume relation at baseline.
 
 Zero pressure of the proxi-
mal and distal valves was set by connecting the airway lumen to the at-
mosphere. The airway was then connected to the pump. Next, the air-
way was cyclically inflated and deflated between 
 
1
 
15 and 
 
2
 
15 cm
H
 
2
 
O using the computerized servo-controlled pump (Figure 2). The
upper pressure limit of 15 cm H
 
2
 
O was chosen because it corresponds
to the plateau of the pressure–volume curve of an air-filled system
(17). This transmural pressure is, therefore, likely to inflate the airway
to a level comparable to TLC. Three complete inflation–deflation cy-
cles were done. After the third cycle, the airway was inflated to 15 cm
H
 
2
 
O at which point the pump automatically stopped. We recorded the
spontaneous pressure drop within 2 min to estimate maximal hystere-
sis and leak.
 
Isobaric contractility and relaxation.
 
 To monitor the contractile
response to methacholine or relaxation response to isoprenaline the
airway was connected to the microplethysmograph. The transmural
pressure was set at 10 cm H
 
2
 
O by adjusting the height of the plethys-
mograph. Baseline volume displacement out of the plethysmograph
was recorded for 2 min before sufficient methacholine or isoprenaline
was added to the organ bath to give a final concentration of 10
 
2
 
4
 
 M.
The isobaric constriction or relaxation was recorded until no more
fluid was displaced into the plethysmograph or until the rate of fluid
displacement out of the plethysmograph became constant.
 
Pressure–volume relation in the presence of methacholine and iso-
prenaline.
 
 These were measured as described for baseline tone.
 
Isobaric relaxation.
 
 To monitor the relaxation response to isopren-
aline the airway was connected to the microplethysmograph. The trans-
mural pressure was set at 10 cm H
 
2
 
O by adjusting the height of the
plethysmograph. Baseline volume displacement out of the plethysmo-
graph was recorded for 2 min before isoprenaline (10
 
2
 
4
 
 M) was added
to the organ bath. The isobaric relaxation was recorded until the rate
of fluid displacement out of the plethysmograph became constant.
 
Pressure–volume relation after isoprenaline.
 
 This was measured as
described for baseline.
 
Fixation.
 
 Finally, the airway was perfused with formalin (10%) from
the distal end at a driving pressure of 10 cm H
 
2
 
O. The valve was closed
as soon as formalin came out of the proximal valve and the Krebs
buffer in the organ bath was quickly replaced with formalin. After fix-
ation for 12 h at a transmural pressure of 10 cm H
 
2
 
O, the airway, in-
cluding the ligatures at both ends, was gently pushed off the cannulas
with forceps and stored in formalin until being processed for histology.
 
Compliance, Hysteresis, Collapsibility, and Contractility
 
Compliance (Cdyn, 
 
m
 
l cm H
 
2
 
O
 
2
 
1
 
) was calculated from the volume in-
fused to inflate the airway from 0 to 15 cm H
 
2
 
O (Figure 2). The transi-
tion point of the pressure–volume curve where inflation changes to
deflation was selected as the upper pressure limit for the Cdyn calcu-
lation because it is least affected by hysteresis. Furthermore, it results
in the Cdyn of the stretched airway close to TLC where collagen is
likely to be an important mechanical determinant (18, 19). Therefore,
Cdyn should be sensitive to changes in airway collagen content. Hys-
teresis (
 
h
 
, 
 
m
 
l cm H
 
2
 
O) was calculated as the area of the pressure–vol-
ume loop between 0 to 15 cm H
 
2
 
O. Collapsibility (Pcol, cm H
 
2
 
O) was
defined as the pressure of the deflation limb where the distal pressure
did not follow the proximal pressure, thus indicating closure of the air-
way lumen. Cdyn, 
 
h
 
, and Pcol were calculated for each cycle. We ana-
lyzed Cdyn, 
 
h
 
, and Pcol of the first cycle (Cdyn
 
1
 
, 
 
h
 
1
 
, and Pcol
 
1
 
) sepa-
rately because we observed that these were always substantially
different from those of the subsequent cycles. The latter were similar
and were therefore taken together (Cdyn, 
 
h
 
, and Pcol). The first cycle
was excluded for analysis when it did not start exactly from 0 cm H
 
2
 
O
transmural pressure. Volume loops could not be analyzed for hystere-
sis in 11 airways where we used a high syringe volume and low speed
of the pump as this caused artifacts in the pressure–volume loops.
To normalize compliance for the volume of the airway segment,
Cdyn
 
1
 
 and Cdyn were divided by the volume of the airway segment as
calculated by morphometry (sCdyn
 
1
 
, sCdyn). Hysteresis was normal-
ized as a percentage of the area of the maximal possible hysteresis
(s
 
h
 
1
 
, s
 
h
 
), which was defined as the product of volume infused and the
upper pressure limit (15 cm H
 
2
 
O). The spontaneous pressure drop
within 2 min after the last inflation was normalized for the inner sur-
face area of the airway (internal perimeter times length) (specific
pressure drop, cm H
 
2
 
O mm
 
2
 
2
 
). We calculated the maximal volume
displaced by the airway segment after methacholine (V
 
M
 
), or isopren-
aline (V
 
I
 
). The response was negative when fluid moved out of the
contracting segment into the plethysmograph and positive when fluid
moved into the relaxing airway segment out of the plethysmograph.
The response was corrected for the rate of baseline fluid movement
before methacholine or isoprenaline was added. To correct for the
volume of the airway segment, V
 
M
 
 and V
 
I
 
 were expressed as the per-
centage of the volume of the airway segment as calculated from mor-
phometry.
 
Airway Dimensions
 
To estimate airway wall dimensions and volume of the lumen, the
segment was cut in cross section at both ends just inside the ligatures,
Figure 2. Example of pressure–volume tracing. The arrowhead shows the direction of the loop. Dynamic
compliance (Cdyn) is the division of infused volume by 15 cm H2O. Specific hysteresis is the area of the
pressure–volume loop above 0 cm H2O expressed as the percentage of the area of the maximal hysteresis.
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decalcified, and embedded in paraffin in such a way that the airway
segment could be cut in cross-section. A random starting point was se-
lected within the first 0.5 mm at one end of the airway using a ran-
domization table. Sections of 5 mm thickness were cut all the way
through the airway with a microtome. Every 100th section (0.5 mm)
was selected for morphometric analysis. We estimated that with this
procedure we could obtain a reliable estimate of the mean airway wall
dimensions. Sections were stained with a combined Gomori trichrome
and elastin stain. This stain resulted in a good color contrast between
airway wall structures. The measurements made are shown in Figure 3
and include: inner perimeter (Pi) and area of the lumen bounded by
the respiratory epithelium (Ai); basement membrane perimeter (Pbm)
and the area enclosed by this perimeter (Abm); the outer muscle pe-
rimeter (Pmo) and the area enclosed by this perimeter (Amo); the outer
perimeter (Po) and the area enclosed by this perimeter (Ao); the area
occupied by smooth muscle (WAm); and the area occupied by carti-
lage (WAcart).
Furthermore, we measured the height of the respiratory epithe-
lium (Hepi) and the fraction of the Pbm covered by epithelium (Fepi).
Hepi was measured as follows. First, a grid containing parallel sinuso-
ids was superimposed over the computer image of the airway. When
respiratory epithelium was present at the point where the sinusoid
crossed the basement membrane, we measured the epithelial height
by drawing a straight line perpendicular from the membrane to the
top of the ciliary border. The length of this line was automatically
computed. When respiratory epithelium was absent, a zero was scored
for height. Second, Hepi was calculated for each airway section by
computing the average of at least 15 epithelial height measurements
around the lumen. Fepi was calculated by dividing the number of inter-
secting points through the basement membrane covered by respira-
tory epithelium with the total number of intersecting points, including
the intersecting points at sites where the respiratory epithelium was
absent. WAepi was calculated by multiplying Pbm by Hepi.
From these measurements we calculated the inner wall area in-
cluding epithelium (WAi 5 Amo 2 Ai), inner wall area excluding epi-
thelium (WAbm 5 Amo 2 Abm), outer wall area (WAo 5 Ao 2 Amo),
and the total wall area (WAtot 5 Ao 2 Ai). This nomenclature was
proposed for quantifying subdivisions in the bronchial wall (20).
Airway dimensions were measured using an automated image
analysis system (KS 400; Kontron Electronic, Eching/Munich, Ger-
many). Measurements of airway dimensions were performed by two
observers (W.H. and H.d.B.). Each observer measured a different set
of airway dimensions for all airways. The interobserver variability was
assessed to compare airway dimensions of this study with a previous
study in which we studied patients with variable degrees of airway
wall thickening (1). This would give us evidence as to whether the pa-
tients we included in the present study had airway wall thickening in
the same range as in previous studies. Both observers remeasured 15
randomly selected airways that were measured by the observer (H.T.)
of the previous study. The intraobserver variability was assessed by re-
measurement of 10 randomly selected airways with an interval of 2 mo.
Inflammatory changes of membranous airways were graded using
the pictorial grading method of Wright and coworkers (21). The fol-
lowing indices were graded in the membranous bronchioles: inflam-
mation, fibrosis, muscle hypertrophy, pigment deposition, goblet cell
metaplasia, and squamous cell metaplasia. For each airway these six
morphological indices were compared with pictorial reference stan-
dards with a score from 0 (normal) to 3 (most abnormal). Next the
mean score for each morphological index for each individual speci-
men was calculated by summing the scores of the airways examined,
divided by the number of airways examined. The average score for
that variable was expressed as a percentage of maximal possible score.
A total membranous airways disease score for each specimen was
then calculated by summing the mean scores of the six morphological
indices (maximal score: 6 3 100 5 600).
Statistical Analysis 
The interobserver and intraobserver variability were calculated by ex-
pressing the difference of the first and the second measurement as a
percentage of the average of both observations. This percentage was
plotted against Pbm to detect systematic errors dependent upon airway
size (22). For each airway and each airway wall dimension, we calcu-
lated the average and the standard error of the mean (SEM). To esti-
mate the accuracy of our morphometric approach, we calculated for
each airway the coefficient of variation of the mean using the formula
(100% 3 SEM)/mean. In this formula, SEM relates to the variation
between sections within a single airway. The relationships between
each airway wall dimension (WAi, WAbm, WAo, WAt, WAm, WAcart,
WAepi, Hepi, Fepi) and airway size (Pbm) were assessed using linear re-
gression analysis. Previous studies found linear relationships between
the square root of airway wall areas and airway size (1, 11, 23–25). We
did a square root transformation on the airway areas of this study,
again resulting in normal distributions of data.
We calculated the average specific compliance, specific hysteresis,
and collapsibility for the first cycle (sCdyn1, sh1, Pcol1) and for the
average of the second, third, and fourth cycle (sCdyn, sh, sPcol) for
all airway segments. Furthermore, we calculated the average specific
pressure drop. This was done for each of the three contractile condi-
tions (baseline, methacholine, and isoprenaline). Repeated-measure-
ments analysis of variance (ANOVA) was used to assess the overall
differences between the three conditions, followed by pairwise t tests
in case the former test was significant. We investigated the correlation
Figure 3. Diagram of measured airway dimensions.
TABLE 1
STUDY POPULATION AND LUNG FUNCTION CHARACTERISTICS
Patients
(n) Mean SD Range
Age, yr 29 61 11 22–73
Sex, male:female 20:9
Lung or lobe resected, right side 14
Lung or lobe resected, left side 15
TLC, % pred 18 100 15 67–132
FRC, % pred 9 108 36 74–190
RV, % pred 18 138 59 65–252
FEV1, % pred 27 80 17 43–106
FVC, % pred 27 99 17 59–135
FEV1/FVC, % 27 65 12 41–85
FEV1/FVC% pred 27 84 15 55–115
RV/TLC% pred 18 129 61 72–273
max50, % pred 11 42 22 11–77
max25, % pred 13 38 22 6–83
DFEV1% pred 23 1 3 27–6
DFEV1% ini 23 1.6 4 28–7
Definition of abbreviations: DFEV1% ini 5 change of FEV1 after bronchodilatation as a
percentage of prebronchodilator FEV1; DFEV1% pred 5 change of FEV1 after broncho-
dilatation as a percentage of predicted FEV1; FEV1/FVC 5 forced expiratory volume in
one second as percentage of forced vital capacity; FEV1/FVC% pred 5 FEV1 as a fraction
of FVC; RV 5 residual volume; RV/TLC% pred 5 RV as a fraction of TLC; max25, %
pred 5 maximal flow at 25% of forced vital capacity; max50 5 maximal flow at 50%
of forced vital capacity.
V·
V·
V
·
V
·
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between the mechanical properties of the second, third, and fourth cy-
cle (sCdyn, sh, Pcol) with airway wall dimensions (WAbm, WAo, WAt,
WAm, WAcart, WAepi, Fepi) using Spearman’s correlation coefficient
(r). When a mechanical property correlated to various airway wall di-
mensions in univariate analysis, we studied their simultaneous effects
using multiple regression analysis. Data are expressed as mean 6
standard deviation and range, unless indicated otherwise. p Values
given are two-sided. In view of the multiple comparisons, p values be-
tween 0.05 and 0.01 are considered as indicative only.
RESULTS
Study Population and Lung Function
Lung function and patient characteristics of the patients with
COPD are shown in Table 1. Out of the group of 27 COPD
patients with preoperative lung function test results, eight pa-
tients had no significant reduction of maximal expiratory air-
flow (FEV1/FVC . 70%), 12 patients had a mild reduction of
maximal expiratory airflow (FEV1/FVC 60 to 70%), and seven
patients had a more severe reduction (FEV1/FVC , 60% pre-
dicted). Increased residual volume [RV . RV(pred) 1 2SD]
was present in five of the 18 patients who had body plethys-
mography. Reversibility of bronchial obstruction defined as
DFEV1% pred . 15% and DFEV1% ini . 15% was not present
in any of the 23 patients.
Airway Segments
We successfully completed all measurements of 35 cannulated
watertight airway segments. The diameter of the cannulas
used was 1.3 6 0.39 (1 to 2) mm; the length of the stretched
airways was 14.2 6 4.2 (6.7 to 21.2) mm. The median of the es-
timated volume of the segments was 30.7 (5.3 to 66.6) ml. Cy-
cling frequency was 3.1 6 1.9, 5 6 5.4, and 1.8 6 0.9 cycles
min21 for baseline, methacholine, and isoprenaline, respectively.
At baseline, after methacholine and isoprenaline, 13, 13, and 2
out of the cycles, respectively, started above 0 cm H2O and
were therefore excluded for analysis.
Compliance, Hysteresis, and Collapsibility
The values for compliance and specific compliance (Cdyn and
sCdyn), hysteresis and specific hysteresis (h and sh), and col-
lapsibility (Pcol) at baseline, after methacholine, and after iso-
prenaline are shown in Table 2 and in Figure 4.
On average, the specific compliance of the first cycle
(sCdyn1) was 13, 11, and 8% below the mean sCdyn of the
subsequent cycles for baseline (p , 0.001), methacholine (p 5
0.03), and isoprenaline (p , 0.001), respectively (Figure 4).
The mean sCdyn after methacholine was 0.009 cm H2O
21 be-
low that of baseline (p 5 0.04). sCdyn after isoprenaline was
0.033 cm H2O
21 higher compared with baseline (p , 0.001)
and 0.042 cm H2O
21 higher compared with methacholine (p ,
0.001). Expressed as percentages, these differences were 4,
101, and 197%, respectively.
The mean specific hysteresis of the first cycle was 34, 30,
and 37% higher compared with sh of the subsequent cycles for
baseline, methacholine, and isoprenaline, respectively (p ,
0.001) (Figure 4). The mean sh after methacholine was not sig-
nificantly different from baseline. sh after isoprenaline was
6.8% lower compared with baseline (p , 0.001) and 7% lower
compared with methacholine (p , 0.001). Expressed as per-
centages, these differences were 9 and 39%, respectively.
The mean pressure drop within the 2 min after the last in-
flation of the compliance measurement was 6.5, 7.1, and 7.2
cm H2O for baseline, methacholine, and isoprenaline, respec-
tively. The mean specific pressure drop for these conditions
was 0.009, 0.001, and 0.001 cm H2O mm
22. The differences be-
tween the three conditions were not significant.
The collapsibility of the first cycle was 0.6, 0.5, and 0.2 cm
H2O below Pcol of the next cycles for baseline, methacholine,
and isoprenaline, respectively (all p , 0.001) (Figure 4). Pcol
after isoprenaline was 1.5 and 1.6 cm H2O above the values at
baseline and with methacholine, respectively (both p , 0.001).
Collapsibility at baseline and after methacholine were not
significantly different. After maximal contraction, there were
five airways that collapsed at pressures of 0 cm H2O or higher.
TABLE 2
MECHANICAL PROPERTIES OF AIRWAY SEGMENTS FOR THE FIRST AND CONSECUTIVE CYCLES*
Condition n
Cycle 1
Mean 6 SD (range) n
Cycles 2, 3, and 4 Average
Mean 6 SD (range)
Cdyn, ml cm H2O
21
Baseline 22 1.45 6 1.0 (0.2 to 3.8) 35 1.52 6 1.0 (0.2 to 3.8)
Methacholine 22 1.36 6 1.1 (0.1 to 3.6) 35 1.42 6 1.1 (0.1 to 3.9)
Isoprenaline 33 2.43 6 1.5 (0.1 to 5.7) 35 2.62 6 1.6 (0.1 to 5.9)
sCdyn, cm H2O
21
Baseline 22 0.053 6 0.02 (0.02 to 0.09) 35 0.059 6 0.03 (0.01 to 0.10)
Methacholine 22 0.049 6 0.03 (0.01 to 0.09) 35 0.052 6 0.03 (0.01 to 0.09)
Isoprenaline 33 0.080 6 0.03 (0.01 to 0.15) 35 0.085 6 0.03 (0.01 to 0.15)
h, m l cm H2O
Baseline 18 75.9 6 71 (4 to 261) 24 55.9 6 54 (1 to 187)
Methacholine 18 70.1 6 81 (6 to 267) 24 43.5 6 45 (3 to 223)
Isoprenaline 25 63.2 6 88 (4 to 268) 26 48.1 6 39 (3 to 138)
sh , %
Baseline 18 19.8 6 9 (4 to 34) 24 13.5 6 7 (1 to 39)
Methacholine 18 18.0 6 11 (4 to 43) 24 12.9 6 8 (2 to 35)
Isoprenaline 25 11.2 6 6 (2 to 28) 26 7.1 6 4 (1 to 16)
Pcol, cm H2O
Baseline 35 24.0 6 5 (216 to 1) 35 23.4 6 5 (217 to 1)
Methacholine 35 24.0 6 5 (216 to 1) 35 23.5 6 4 (216 to 1)
Isoprenaline 35 22.1 6 3 (211 to 1) 35 21.9 6 2.6 (211 to 1)
* Mechanical properties of isolated airway segments at baseline, after contraction with methacholine, and after relaxation with isoprena-
line. The mechanical properties examined are compliance Cdyn, hysteresis h , and collapsibility Pcol. Compliance was normalized for airway
volume (sCdyn) and hysteresis for the maximal possible hysteresis (sh ). The values for the first cycle and for the average of the consecutive
cycles are shown separately because the mechanical properties of the first cycle were different from that of consecutive cycles.
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After maximal relaxation, this number increased to nine. Pcol
and sCdyn after methacholine were significantly correlated (r 5
0.54, p 5 0.001). In other words, the stiffer the airway after
methacholine, the less collapsible it was.
The median fluid volume displaced by methacholine-induced
constriction was 29.4 (241 to 10) ml or 237 (2103 to 119) %
of the estimated airway volume. For the relaxing airway after
isoprenaline these values were 5.9 (27 to 46) ml or 31.4 (214
to 58) %.
Airway Dimensions
The intra- and interobserver variability were well below 10%
and 15%, respectively, for each of the airway wall dimensions.
There was no systematic relationship between airway size
(Pbm) and the intra- or interobserver variability for any vari-
able. The mean coefficients of variation of the individual
means for the airway dimensions for Pbm, WAbm, WAo, WAt,
WAm, WAcart, Hepi, and Fepi were 4, 6, 8, 8, 10, 33, 12, and 13%,
respectively. Characteristics of the airways are shown in Table
3. Highly significant (p , 0.002) linear relations were found
between the square root of all airway wall areas and Pbm.
There was a positive correlation between Hepi and Pbm (r 5
0.43, p 5 0.02); in other words, the epithelial layer in large air-
ways was higher compared with small airways. Furthermore,
there was a positive correlation between Fepi and Pbm (r 5
0.39, p 5 0.04), meaning there was more loss of epithelium in
smaller airways. The average Hepi was 10.7 6 6.3 (0.1 to 28.7)
mm and Fepi was 53 6 24 (1 to 96) %. The membranous air-
ways disease score was 119 6 40 (38 to 223).
Lung Function versus Compliance,
Hysteresis, and Collapsibility
Specific hysteresis at baseline correlated to FEV1/FVC (r 5
20.57, p 5 0.06) and RV/TLC% pred (r 5 0.5, p 5 0.05). Hys-
teresis after methacholine correlated to FEV1/FVC (r 5
20.68, p 5 0.02), RV (r 5 0.5, p 5 0.05), and RV/TLC% pred
(r 5 0.67, p 5 0.007). There was no correlation between hys-
teresis and parameters of reversibility (DFEV1% pred and
DFEV1% ini). Specific compliance and collapsibility did not
correlate to the parameters as mentioned previously.
Airway Dimensions versus Compliance,
Hysteresis, and Collapsibility
Specific compliance (sCdyn) at baseline, after methacholine,
and after isoprenaline was independent of airway size (p 5
0.2). Specific compliance at baseline correlated significantly to
the total wall area (WAt) (r 5 20.35, p 5 0.04) and outer wall
area (WAo) (r 5 20.39, p 5 0.02), not to other airway wall ar-
eas. Because the WAt components WAepi and WAbm did not
correlate to sCdyn, we conclude that of all factors studied
WAo is the most important component for sCdyn at baseline,
accounting for 15% of the variability. After methacholine,
sCdyn correlated negatively to the amount of smooth muscle
(WAm) (r 5 20.37, p 5 0.05) and to the area of epithelium
(WAepi) (r 5 20.37, p 5 0.05). Because of the strong correla-
Figure 4. Dynamic properties of isolated airway segments at base-
line, after methacholine, and after isoprenaline. (A) Specific com-
pliance (sCdyn). (B) Specific hysteresis (sh). (C) Collapsibility Pcol.
The error bars represent the SEM. Closed circles represent the first
cycles, closed squares the average of the second, third, and fourth
cycle. Arrows denote comparisons between squares. B 5 baseline;
MCh 5 methacholine (1024 M); Iso 5 isoprenaline (1024 M). *p 5
0.03; **p , 0.001.
TABLE 3
DIMENSIONS OF ISOLATED AIRWAY SEGMENTS
Airway Dimensions Mean 6 SD (range)
Internal perimeter, mm 6.1 6 1.2 (4.1–8.4)
Airway wall thickness, mm 0.3 6 0.1 (0.11–0.61)
Length of airway segment, mm 14.2 6 4.2 (6.7–21.2)
Equations of airway dimensions (in mm)
as a function of airway size
Wall area basement membrane, WAbm WAbm 5 0.19 1 0.071 Pbm
Outer wall area, WAo WAo 5 20.15 1 0.206 Pbm
Total wall area, WAtot WAt 5 20.06 1 0.226 Pbm
Smooth muscle area, WAm WAm 5 0.04 1 0.034 Pbm
Cartilage area, WAcart WAcart 5 20.18 1 0.067 Pbm
Epithelial area, WAepi WAepi 5 20.01 1 0.042 Pbm
Ö
Ö
Ö
Ö
Ö
Ö
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tions of WAm and WAepi, no conclusion about which of the
two variables was more predictive for sCdyn could be ob-
tained using multiple regression analysis. Specific compliance
after isoprenaline did not correlate to any of the airway di-
mensions. The difference between sCdyn after isoprenaline
and methacholine correlated significantly to WAm (r 5 0.45,
p 5 0.02) but not to WAepi. The difference between sCdyn1
and sCdyn at baseline, after methacholine, and isoprenaline
did not correlate to any airway wall dimension.
Specific hysteresis (sh) at baseline was positively correlated
to WAt (r 5 0.41, p 5 0.04) and to WAm (r 5 0.44, p 5 0.04),
but not to other airway wall dimensions (WAbm, WAcart,
WAepi). Because WAt and WAm were significantly correlated,
it was not possible to differentiate whether WAt or WAm was
the most predictive dimension for sh in a multiple regression
model. Specific hysteresis after methacholine correlated to
WAt (r 5 0.54, p 5 0.006), WAo (r 5 0.52, p 5 0.01), and
WAm (r 5 0.6, p 5 0.004), and to WAcart (r 5 0.42, p 5 0.04).
Multiple regression analysis showed that WAm was the only
remaining significant predictive dimension (p 5 0.01). Specific
hysteresis after isoprenaline did not correlate to any of the air-
way dimensions. The difference between sh1 and sh at base-
line, after methacholine, and after isoprenaline did not corre-
late to any airway wall dimension.
The specific pressure drop after the fourth inflation, indi-
cating hysteresis and leak, was correlated negatively to all air-
way dimensions for baseline, after methacholine, and after
isoprenaline (p , 0.01). Multiple regression analysis showed
that at baseline, WAepi was the only remaining significant pre-
dictive dimension for the pressure drop. After methacholine,
WAo was the only significant dimension (p 5 0.04) determin-
ing the pressure drop. After isoprenaline, multiple regression
analysis showed that WAo and WAepi were both predictive.
Because of the strong correlations between the two, no con-
clusion about which variable was most predictive could be
obtained. Thus, small airways with thinner epithelium and
smaller outer airway wall area had a faster pressure drop after
the final inflation.
Pcol of the airways at baseline, after methacholine, and af-
ter isoprenaline did not correlate to any of the airway wall di-
mensions (WAbm, WAo, WAt, WAm, WAcart, WAepi).
DISCUSSION
Chronic inflammation of the airways results in fibrous tissue
deposition and thickening of the airway wall. We thought it
likely that this remodeling makes the airway less compliant.
Our results show that of the airway dimensions studied the
bronchial smooth muscle area, not total wall area, is the most
important determinant for airway compliance, hysteresis, and
collapsibility.
Compliance
Airway compliance is an important predictor of airway diame-
ter and lung compliance (26, 27). We expected that the inner
and outer wall area of airways from smokers with varying de-
grees of airflow obstruction would be important determinants
of sCdyn for a number of reasons. The inner and outer wall
area correlated positively to inflammatory changes within the
airway wall in smokers (1, 11). Furthermore, chronic airway
inflammation is related to an increased amount of fibrous tis-
sue within the airway wall (10, 11, 23) which is likely to make
the airway stiffer. Though sCdyn correlated to the outer air-
way wall area at baseline tone, no correlation was present
between the outer and inner wall area and sCdyn after maxi-
mal relaxation of bronchial smooth muscle tone. After maxi-
mal contraction of the smooth muscle, sCdyn decreased and
smooth muscle area was the most important airway dimension
for sCdyn. We believe that the weak correlation between
WAm and sCdyn may well underestimate the importance of
smooth muscle for airway compliance. Our measurement of
WAm included not only smooth muscle cells but also connec-
tive tissue within the smooth muscle bundles, which increases
the variability of the WAm measurement. Furthermore WAm
is likely to be a poor estimate of the stress that can be gener-
ated by the smooth muscle as this is also dependent on the
orientation of the muscle bundles in the airway wall, which
was not assessed in our study. How can we explain that the
inner and outer wall area did not correlate to sCdyn? It could
be that the airways we investigated were not thickened by
chronic inflammation. We think this is unlikely because the
selection criteria for patients and lung tissue were the same
as for previous studies (1, 11, 23–25). Furthermore, we inves-
tigated small airways, where inflammatory changes are known
to be most severe (1). Finally, inflammation scores were
within the same range as in a previous study (1) and these
scores are known to correlate positively to the inner and outer
airway wall area. The lack of correlation between inner and
outer wall area and sCdyn could also be explained by assum-
ing that these areas correlate poorly to the presence of struc-
tural components important for sCdyn such as collagen.
Specific compliance at baseline was two-thirds of sCdyn of
the maximally relaxed airway. The initially high intrinsic con-
tractile state could partly be an artifact related to our tissue
preparation. Loss of epithelium was present in many of the
airways we studied. Epithelium is a well-known source of
bronchodilating substances (28) and its loss might therefore
have increased smooth muscle tone. However, sCdyn at base-
line did not correlate significantly to the percentage of the
basement membrane covered by epithelium. Furthermore,
sCdyn at baseline in our study was only slightly higher than
other in vivo studies of human airways, taking into account
differences in methodology (29–32). If there is a high smooth
muscle tone in vivo too, then it is puzzling why none of the pa-
tients in our study and only one of 58 patients in a previous
study showed reversibility after bronchodilatation (1). How
can this discrepancy be explained? In our experimental setup
airways were inflated by a mechanical pump. In vivo, airways
are dilated by tethering forces of alveolar attachments in rela-
tion to breathing cycles. We speculate that in lungs of patients
with COPD loss of alveolar attachments results in absence
or incomplete dilation of segments or complete membranous
airways, even after adequate relaxation of bronchial smooth
muscle.
Hysteresis
Smooth muscle tone is known to be an important contributor
to hysteresis (33, 34). We found a significant decrease of sh
with maximal relaxation compared with baseline and with the
maximally contracted airways. However, we did not find a dif-
ference between sh at baseline and after maximal contraction
of the smooth muscle. This can be explained by the smaller in-
crease in volume necessary to inflate a contracted airway to
the pressure limit of 15 cm H2O. Surprisingly, a substantial
portion of the sh was not contributed by smooth muscle tone.
After maximal relaxation, mean sh was still 53% of baseline
sh. Hysteresis of lung tissue is related to four different mecha-
nisms: kinetics of cross-bridge attachment–detachment, kinet-
ics related to the surface film, kinetics of fiber–fiber network-
ing within the connective tissue matrix, and the kinetics of
recruitment–derecruitment (35). For the sh of fluid-filled re-
laxed airway segments in our study kinetics of cross-bridge at-
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tachment–detachment, surface tension, and recruitment do
not play an important role. Therefore, it is likely that sh of re-
laxed airway segments originates within the connective tissue
matrix of the airway wall.
At baseline, sh was correlated both to the smooth muscle
area and to total airway wall area. After maximal contraction
of the smooth muscle, its area was the single most important
airway wall dimension related to sh. After maximal relaxation,
the total wall area was not correlated to sh. These findings
suggest that the total wall area does not reflect changes in the
fibrous tissue composition which determines sh. A surprising
finding was that specific hysteresis at baseline and after meth-
acholine correlated to in vivo lung function parameters of air-
flow obstruction. If not a false-positive finding, this might re-
flect the role of smooth muscle tone in the pathogenesis of
airflow obstruction in COPD.
Collapsibility
To our knowledge, this is the first study on the relation be-
tween collapsibility and airway dimensions of human small
airways. Collapsibility was correlated to smooth muscle tone
and not to any of the airway dimensions. Reduction of smooth
muscle tone made the airway more compliant and more col-
lapsible. Airways with the biggest change in compliance be-
tween the maximally contracted and maximally relaxed state
also had the biggest change in collapsibility. Many airways col-
lapsed at negative pressures close to 0 cm H2O or higher. In
vivo these airways will depend on parenchymal recoil pressure
to remain open. The use of bronchodilators in patients might
therefore facilitate airway closure during expiration. The im-
portance of smooth muscle tone for the collapsibility of large
airways has been reported for different animal species (36–
39). We conclude that collapsibility of small airways will to an
important degree depend on smooth muscle tone and paren-
chymal support.
Effects of Volume History
The mechanical characteristics of the first cycle were substan-
tially different from the subsequent cycles. On the first cycle,
airways were less compliant, had a greater hysteresis, and
were less collapsible compared with subsequent cycles. Similar
findings were obtained earlier in bronchi and tracheal strip
preparations from dogs (33, 40). In vivo, the effect of volume
history on compliance and hysteresis has been described for
normal subjects, asthmatics, and patients with COPD (41–44).
In the general population and in COPD patients a deep inha-
lation results in bronchodilatation (41, 44). In asthmatics deep
inhalation can result in bronchoconstriction or bronchodilata-
tion. In COPD, this effect is reduced but still present after in-
halation of bronchodilators (44). We found that the difference
in sCdyn and sh between the first and the subsequent cycles
persisted even after maximal relaxation by isoprenaline. We
therefore conclude that the effect of volume history on sCdyn
and sh is not only related to smooth muscle tone but also to
connective tissue within the airway wall.
Conclusions
In this study smooth muscle area and tone, but not total wall
area, were the most important morphological correlates for
the dynamic properties of isolated airways from smokers. We
showed that maximal bronchodilatation doubled compliance,
reduced hysteresis, and increased collapsibility of airway seg-
ments independently of airway wall thickness. The volume
history of the isolated airway segments had a substantial effect
on compliance, hysteresis, and collapsibility even in the ab-
sence of smooth muscle tone.
It was striking that isolated airways showed considerable
reversibility of bronchoconstriction whereas in vivo patients
with COPD have very little reversibility of airflow obstruction
after inhalation of bronchodilators (1, 45). We speculate that
in patients with COPD loss of alveolar attachments is respon-
sible for absence or incomplete dilatation of segments of mem-
branous airways, even after effective relaxation of bronchial
smooth muscle.
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